Midweek Takeaway with James Short, CEO of Celadon Pharmaceuticals (AIM:CEL) #CEL
Season 9, Episode 7, Sep 12, 12:55 PM
In this week's Midweek Takeaway, we’re joined by James Short, CEO of Celadon Pharmaceuticals, to discuss their exciting collaboration with Valeos Pharma in Denmark. James shares insights on how this partnership could double production capacity to 3 tonnes of medical-grade cannabis annually, potentially worth up to £30 million. We’ll also explore the financial impact, including the potential £1.7 million annual contribution to Celadon, and what this means for the company’s future. Tune in for an in-depth look at the numbers and strategy behind Celadon's growth in the European market!
Disclaimer & Declaration of Interest
The information, investment views, and recommendations in this podcast are provided for general information purposes only. Nothing in this podcast should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.
Disclaimer & Declaration of Interest
The information, investment views, and recommendations in this podcast are provided for general information purposes only. Nothing in this podcast should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.